ArticleOncotarget2015

HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.

Ran Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.